mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-11 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-07 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-07 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-07 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-07 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-06 |